CN112359043B - CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof - Google Patents
CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof Download PDFInfo
- Publication number
- CN112359043B CN112359043B CN202011285033.7A CN202011285033A CN112359043B CN 112359043 B CN112359043 B CN 112359043B CN 202011285033 A CN202011285033 A CN 202011285033A CN 112359043 B CN112359043 B CN 112359043B
- Authority
- CN
- China
- Prior art keywords
- phomopsis
- crispr
- vector
- rrna
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 67
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 31
- 241001480007 Phomopsis Species 0.000 title claims abstract description 29
- 238000010276 construction Methods 0.000 title claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 241000233866 Fungi Species 0.000 claims abstract description 13
- 239000012634 fragment Substances 0.000 claims description 34
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 12
- 108020005075 5S Ribosomal RNA Proteins 0.000 claims description 10
- 210000001938 protoplast Anatomy 0.000 claims description 10
- 108020004414 DNA Proteins 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 238000012795 verification Methods 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000012163 sequencing technique Methods 0.000 claims description 5
- 238000001976 enzyme digestion Methods 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 102000012410 DNA Ligases Human genes 0.000 claims description 3
- 108010061982 DNA Ligases Proteins 0.000 claims description 3
- 230000001404 mediated effect Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims 1
- 238000003209 gene knockout Methods 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 230000001851 biosynthetic effect Effects 0.000 abstract description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 3
- 229920001470 polyketone Polymers 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 241000461379 Diaporthe lithocarpus Species 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 150000002611 lead compounds Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- DYNXQZCWMXLZCW-UHFFFAOYSA-N 6-hydroxy-2-[3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxine-5-carbonyl]-3-(3-methylbut-2-enyl)benzaldehyde Chemical compound CC(C)=CCC1=CC=C(O)C(C=O)=C1C(=O)C1=CC(C)=CC2=C1OC(C(C)(C)O)CO2 DYNXQZCWMXLZCW-UHFFFAOYSA-N 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 108020005004 Guide RNA Proteins 0.000 description 2
- 241001633106 Lithocarpus Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000000830 polyketide group Chemical group 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- -1 lithoacarpins A-G Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a CRISPR/Cas9 vector applicable to phomopsis FS508 and a construction method and application thereof. The invention firstly utilizes CRISPR/Cas9 technology to construct a recombinant P.lithacarpus FS508 strain with a knocked-out polyketone new skeleton compound lithacarpus biosynthetic gene, and establishes a CRISPR/Cas9 gene knockout system suitable for deep sea fungi P.lithacarpus FS508, thereby laying a molecular biological foundation for the elucidation of the biosynthetic mechanism of the lithacarpus in the P.lithacarpus FS508 and the obtainment of more lithacarpus polyketone derivatives with remarkable anti-tumor activity.
Description
Technical Field
The invention belongs to the technical field of molecular biology, and particularly relates to a CRISPR/Cas9 vector applicable to phomopsis FS508, and a construction method and application thereof.
Background
The deep sea fungus Phomopsis lithocarpus FS508 is a Phomopsis from deep sea, which produces a large number of novel skeletal polyketides lithocarpins of the tenolone-decamacrolide group with significant antitumor activity. At the early stage, 7 ten-membered macrolide hybrid teneellone polyketone new skeleton compounds, namely lithoacarpins A-G, are obtained from deep sea fungi, namely, Phomopsis lithoacarpus, and the new skeleton compounds have stronger cytotoxic activity on tumor cells, wherein lithoacarpin E has better selective cytotoxic effect, the cytotoxicity on hepatoma carcinoma cells HepG-2 is obviously stronger than that of other tumor cells, and the lithoacarpin E has the potential of being developed into a lead compound of a specific anti-liver cancer medicament. On this basis, p. lithacarpus FS508 was subjected to genome sequencing, and the biosynthetic gene cluster of lithacarpins was predicted. The lithocarpins polyketide backbone is predicted to be formed catalytically by PKS on cluster 41, where the KS (ketoacyl synthase) module is the starter module for PKS genes. It is therefore necessary to mutate or delete this module in order to verify its function in the process of biosynthesis of litocarpines. However, the biosynthesis mechanism of lithoacarpins has not been elucidated, since the gene knockout system of the deep sea fungus phomopsis p. The establishment of a gene knockout system of P.lithacarpus FS508 is beneficial to the analysis of a lithacarpus biosynthesis mechanism, so that more novel lithacarpus compounds and derivatives thereof can be obtained through a synthetic biology strategy.
CRISPR/Cas9 is a technology for specific DNA modification of targeted genes by sgRNA mediated Cas9 nuclease. Can cut the target gene under the guidance of gRNA. The CRISPR/dCas9 is obtained by mutating the active region to lose the cutting activity, and the transcription regulation of target gene is modified by fusing partial transcription regulation elements and methylation modification elements. The CRISPR/Cas9 system has very wide application in genome editing of eukaryotic cells such as mammalian cells, stem cells and plants due to the advantages of simple construction, relatively high gene knockout efficiency, low cost and the like, but the CRISPR/Cas9 system has relatively low knockout efficiency in filamentous fungi and needs further optimization due to the relatively complex genetic background caused by the unique habitat of the deep-sea fungi, and the CRISPR/Cas9 system is not applied to gene knockout of deep-sea fungus phomopsis.
Disclosure of Invention
The invention aims to overcome the current situation that the existing deep sea fungus P.lithocarpus FS508 lacks an effective genetic operation means, and provides a CRISPR/Cas9 vector suitable for phomopsis FS508 and a construction method and application thereof.
The first purpose of the invention is to provide a construction method of CRISPR/Cas9 vector suitable for Phomopsis FS508, which comprises the following steps:
designing a target sequence 5'-gagaaggcttacgctcaggt-3' of a KS module on the basis of a pFC332 vector, designing and respectively amplifying a 5S rRNA fragment and a sgRNA fragment containing the target sequence, and then carrying out fusion PCR by taking the 5S rRNA fragment and the sgRNA fragment containing the target sequence as mixed templates to obtain a 5S rRNA-KS-sgRNA fragment;
the pFC332 vector and the 5SrRNA-KS-sgRNA fragment are subjected to double digestion by restriction enzymes PacI and BglII, then the 5S rRNA-KS-sgRNA fragment is connected into the pFC332 vector by T4 DNA ligase, the connection product is transformed into a Trans5 alpha competent cell, Amp resistance selection is carried out, and the 5S rRNA-KS-sgRNA fragment is amplified for verification, so that the CRISPR/Cas9 vector suitable for the Phomopsis FS508 is obtained.
Preferably, the nucleotide sequence of the 5S rRNA fragment is shown in SEQ ID No.1, and the nucleotide sequence of the sgRNA fragment containing the target point sequence is shown in SEQ ID No. 2.
The invention also provides a CRISPR/Cas9 vector which is constructed according to the construction method and is suitable for the phomopsis FS 508.
The invention also provides a fungus containing the CRISPR/Cas9 vector applicable to the Phomopsis FS 508.
Preferably, the fungus is Phomopsis FS 508.
The invention also provides application of the CRISPR/Cas9 vector suitable for the phomopsis FS508 in gene knock-out of the phomopsis FS 508.
Preferably, the method comprises the following steps: introducing the CRISPR/Cas9 vector suitable for the Phomopsis FS508 into a Phomopsis FS508 protoplast by a protoplast-mediated method, screening by a hygromycin-resistant PDA plate, selecting a positive clone, extracting genome DNA to verify the introduction of a recombinant vector, and verifying the knockout of a target gene by sequencing.
The CRISPR/Cas9 vector suitable for deep sea fungi phomopsis p.lithachus FS508 is constructed, key biosynthesis genes of a new skeleton antitumor compound are knocked out, the function of a target gene is further verified through metabolite comparison analysis, a molecular biological basis is laid for analyzing the lithacarpine biological mechanism synthesis in p.lithachus FS508 in the later stage, and the development and utilization of the lithacarpine compounds in the aspect of antitumor drug lead compounds are promoted.
Compared with the prior art, the invention has the following beneficial effects:
at present, the gene knockout of fungi is generally carried out by adopting a method of introducing a target gene homology arm to generate homologous recombination, but two repair modes of non-homologous end repair and homologous recombination exist in filamentous fungi, and the generation efficiency of homologous recombination is low, so that the gene knockout of the filamentous fungi is slow in progress, and the genetic operation modification and the discovery of novel secondary metabolites of the filamentous fungi are seriously hindered. The CRISPR/Cas9 gene knockout system has the advantages of simple vector construction, relatively high gene knockout efficiency and the like, the Cas9 protein cuts the position of about 3bp near a target sequence NGG, and the deletion, mutation or insertion of a target gene is caused by NHEJ repair, so that the expression of the target gene is damaged, and therefore the CRISPR/Cas9 system can effectively promote the genetic engineering transformation of deep sea fungi P.lithocarpus FS508, and more lead compounds with biological activity are discovered.
Lithocarpus FS508, a deep sea fungus of the present invention, is disclosed in patent application No. CN201810974840.6, entitled: compound litocarpinol B, a preparation method thereof and application thereof in preparing antifungal medicaments.
Drawings
FIG. 1 shows the construction of pFC 332-sgRNA-KS; wherein, FIG. A shows the construction of 5S rRNA-KS-sgRNA fragment, lane 1 shows the 5S rRNA fragment, lane 2 shows the sgRNA fragment, and lane 3 shows the 5S rRNA-KS-sgRNA fragment; FIG. B is a PCR-verified plot of the bacterial solution of the recombinant vector pFC332-sgRNA-KS, wherein lane 1 is a blank control, and lanes 2-6 are PCR results of the bacterial solution;
fig. 2 is a hygromycin-resistant PDA plate of recombinant vector pFC332-sgRNA-KS introduced into p.
FIG. 3 shows the Cas9 gene amplification verification of recombinant vector KS-pFC332-sgRNA introduction; m is DNA marker, Lane 1 is blank control, Lane 2-11 is PCR product of bacterial liquid, Lane 12 is positive control;
figure 4 is a graph of the amplification of the target gene from the p. lithocarpus FS508 KS module; m is DNA marker, lanes 1-10 are target gene KS amplified by using recombinant bacterium genome DNA as a template;
figure 5 is a verification chart of sequencing of deletion mutations of the target gene of the p. lithocarpus FS508 KS module;
figure 6 is a graph comparing secondary metabolites of KS mut p. lithocarpus FS508 and wild p. lithocarpus FS508, with lithocarpin and teneellone as standards.
Detailed Description
The following examples are further illustrative of the present invention and are not intended to be limiting thereof.
Example 1: construction of targeted litocarpins biosynthesis gene knockout vector
Target sequences 5'-gagaaggcttacgctcaggt-3' for the KS module were designed.
On the basis of pFC332 plasmid, PacI and BglII sites are subjected to double digestion on pFC332, and a sequence is inserted: a 5S rRNA-KS-sgRNA fragment (i.e., 5S rRNA promoter-targeting sequence-sgRNA terminator, including a 5S rRNA promoter suitable for use in p.lithacarpus FS508, a sgRNA targeting sequence backbone gene functional in p.lithacus FS508, and its terminator) enables the recombinant plasmid to stably express Cas9 protein and transcribe sgRNA simultaneously after transformation into protoplasts (the plasmid is designated as pFC 332-sgRNA-KS). Wherein the primer 5S rRNA-sgRNA-F contains the target sequence gagaaggcttacgctcaggt in the KS module.
Primers designed for constructing the vector are shown in table 1, and a pFC332-sgRNA-KS vector is constructed by utilizing an enzyme digestion connection mode. The construction method is specifically as follows:
TABLE 1 primer sequences
PCR amplification was performed using Prime STAR MAX (TAKARA, Japan) high fidelity premix using P.lithocarpus FS508 genomic DNA as a template and primers 5SrRNA-promoter-F and 5S rRNA-promoter-R as primers and the like to obtain fragment 1 (the nuclear fragment thereof) of the 5S rRNA promoter containing a BglII cleavage siteThe nucleotide sequence is shown as SEQ ID NO.1, and figure 1A). Reaction system 50 μ L: 5S RNA-F0.5. mu.L, 5S RNA-R0.5. mu.L, 5S RNA 1. mu.L, 2 XPrime star 25. mu.L, ddH2O23. mu.L. PCR procedure: pre-denaturation at 98 ℃ for 5min, denaturation at 98 ℃ for 10s, annealing at 55 ℃ for 15s, extension at 72 ℃ for 10s, 35 cycles, and final extension at 72 ℃ for 10 min.
Artificially synthesizing sgRNA and a Terminator sequence thereof as a template, and carrying out PCR amplification by using primers 5SrRNA-sgRNA-F (containing KS target gRNA) and sgRNA-Terminator-R as front and rear primers to obtain a fragment 2 (the nucleotide sequence of which is shown in SEQ ID NO. 2) containing a PacI enzyme cutting site, the sgRNA and a Terminator thereof.
Using the fragments 1 and 2 prepared above as a mixed template, fusion PCR was performed using Prime STAR MAX (TAKARA, Japan) high fidelity premix to obtain a 5S rRNA-KS-sgRNA fragment (FIG. 1A). PacI and BglII double enzyme digestion (Fermentas, USA) is carried out on pFC332 plasmid, PacI and BglII double enzyme digestion is carried out on the obtained 5S rRNA-KS-sgRNA fragment, the cut 5S rRNA-KS-sgRNA fragment is connected to the cut pFC332 by T4 DNA ligase, the connection product is transformed into Trans5 alpha competent cells, Amp resistance screening is carried out, bacterial liquid PCR verification is carried out by amplifying the fusion fragment (figure 1B), and the CRISPR/Cas9 vector of the KS module of the targeting P.lithacarpus FS508 is obtained and named as pFC 332-sgRNA-KS.
Example 2: knock-out of the lithacarpus FS508 lithacarpine biosynthetic gene:
introduction of foreign genes into p. lithocarpus FS508 protoplasts method was as follows:
(1) lithocarpus FS508 protoplasts were prepared as follows:
a suitable amount of P.lithocarpus FS508 mycelia was inoculated into 200mL of PDB liquid medium and cultured at 30 ℃ at 180r/min for 7 days. Filtering the bacterial liquid by two layers of gauze, selecting 2g (wet weight) of the bacterial balls with better growth in a 50mL centrifuge tube, and washing twice by PBS buffer solution to fully wash away the residual PDB culture medium. 0.10g of lyase was weighed out and dissolved in 20mL of KC buffer (0.6M KCl, 0.05M CaCl)2) And filtered through a 0.22 μm filter membrane and added to the washed pellet. The cells were lysed at 28 ℃ and 68rpm for about 3 hours. Filtering the lysate with 200 mesh filter screen, filtering mycelium, and reusingThe 6 layers of the lens-wiping paper are filtered again, centrifuged at 4000 Xg for 5min at 4 ℃ and the supernatant is discarded. Add 5mL KC buffer solution, gently blow the precipitate with pipette, mix well, centrifuge at 4 deg.C at 4000 Xg for 5min, discard the supernatant. Adding 1mL of KC buffer solution, resuspending, namely finishing the preparation of the protoplast, performing microscopic examination, and observing the shape and the number of the P.lithocarpus FS508 protoplast;
prepared protoplast of P.lithocarpus FS508 (1X 10)8/mL) and 5 mu g pFC332-sgRNA-KS plasmid, placing on ice for 5min, then adding 200 mu L of PEG4000 with volume fraction of 30%, placing at 30 ℃ for 15min, then adding 400 mu L of PEG4000, placing at 30 ℃ for 15min, then adding 1.2mL of W5 solution to terminate the reaction, finally adding 4mL of WI buffer solution, placing on a 30 ℃ shaking table at 80rpm, and culturing overnight for later use;
(2) cooling the melted PDA solid culture medium to room temperature, taking 20mL each time, gently mixing with the overnight culture solution in the step (1), adding hygromycin with the final concentration of 100 mug/mL, uniformly coating the mixture, and culturing for 5d at 30 ℃;
(3) after a small mycelium grows out, picking a fungus colony to be transferred to a PDA culture medium containing hygromycin with the final concentration of 100 mu g/mL, and then screening;
(4) the positive clones (fig. 2) growing on the hygromycin PDA plate in step (3) are first preserved (i.e. part of the mycelia is picked and transferred to a new hygromycin PDA plate), then the remaining fungal mycelia are placed in a sterile EP tube, liquid nitrogen is added to the sterile EP tube to fully grind the mycelia, the mycelia are immediately placed in a 100 ℃ water bath for 5min, then placed in liquid nitrogen for 1min again, the process is repeated for 3 times, finally 50 mul of ultrapure water is added to dissolve the mycelia, the mycelia are centrifuged at the maximum speed for 5min, and the supernatant (i.e. total genomic DNA) is taken and placed at-20 ℃ for preservation. Cas9 gene front and back primers Cas9-F and Cas9-R (see Table 1) are designed to amplify a Cas9 gene sequence to verify whether the recombinant vector pFC332-sgRNA-KS is successfully introduced (figure 3); on the basis of successful introduction, KS front and back primers (KS-Ver F, KS-Ver R, see table 1) of the target gene KS are designed to amplify a KS fragment (figure 4), and sequencing, alignment and verification are carried out.
In total, 10 clones were selected for sequencing, of which 1#, 2#, 3#, 4# and 7# underwent gene mutation, 2 bases A near the target site were deleted (FIG. 5), and the KS module failed to work normally. The efficiency of gene mutation was 50%, and the successfully obtained gene-deleted strain was recombinant p. lithocarpus FS508(KS mut p. lithocarpus FS 508).
Example 3: comparative analysis of litocarpines in KS mutant and wild strains
Comparative analysis of the yield of novel lithoacarpins from wild p.lithoacarpus FS508 and recombinant p.lithoacarpus FS 508.
Recombinant p.lithacarpus FS508(KS mut p.lithacarpus FS508) and wild p.lithacarpus FS508 were inoculated, cultured in YPD medium, and cultured at 28 ℃ for 7 days. Fermentation broths of wild and recombinant p. lithocarpus FS508 were collected, extracted with equal volume of ethyl acetate and concentrated by rotary evaporation. Crude extracts of wild p.lithacarpus FS508 and recombinant p.lithacarpus FS508 ethyl acetate were analyzed by HPLC and Agilent 6430 HPLC and novel lithacarpin a and Tenellone B from p.lithacarpus FS508 were used as standards. With C18The column (4.6X 250mm) was analyzed. The detection conditions are as follows: the eluent was increased from 30% methanol to 100% methanol in 50min at a flow rate of 1.0 mL/min. The HPLC detection analysis result shows that the wild P.lithocarpus FS508 can detect the chromatographic peak corresponding to lithocarpin A (42.5 min). Whereas in crude recombinant p.lithacarpus FS508(KS mut p.lithacus FS508) no chromatographic peaks corresponding to lithacarpin a and teneellone B could be detected at the corresponding positions (fig. 6). The results show that the KS module can not generate litocarpin A by mutational inactivation of the KS module by using the CRISPR/Cas9, so that the key effect of the KS module in the litocarpin biosynthesis process is proved, and the CRISPR/Cas9 system is also suitable for knocking out the target gene of the KS mut P. litocarpus FS508 and has high knocking-out efficiency.
Sequence listing
<110> Guangdong province institute for microbiology (Guangdong province center for microbiological analysis and detection)
<120> CRISPR/Cas9 vector applicable to Phomopsis FS508 and construction method and application thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 128
<212> DNA
<213> Phomopsis lithocarpus FS508)
<400> 1
cgcagatctc acatacgacc acagggtgtg gaaaacaggg cttcccgtcc gctcagccgt 60
acttaagcca cacgccggga ggttagtagt tgggtgggtg accaccagcg aatcccttct 120
gttgtatg 128
<210> 2
<211> 205
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
cgaatccctt ctgttgtatg gagaaggctt acgctcaggt gttttagagc tagaaatagc 60
aagttaaaat aaggctagtc cgttatcaac ttgaaaaagt ggcaccgagt cggtggtgct 120
ttttttgttt tttatgtctg aattctgcag atatccatca cactggcggc cgctcgagca 180
tgcatctaga gggccgctta attaa 205
Claims (6)
1. A construction method of CRISPR/Cas9 vector of Phomopsis FS508 is characterized by comprising the following steps:
designing a target sequence 5'-gagaaggcttacgctcaggt-3' of a ketoacyl synthase module on the basis of a pFC332 vector, designing and respectively amplifying a 5S rRNA fragment and a sgRNA fragment containing the target sequence, and then carrying out fusion PCR by taking the 5S rRNA fragment and the sgRNA fragment containing the target sequence as mixed templates to obtain a 5S rRNA-KS-sgRNA fragment;
using restriction endonucleasesPacI andBglII, double enzyme digestion of pFC332 vector and 5S rRNA-KS-sgRNA fragment, then connecting the 5S rRNA-KS-sgRNA fragment into pFC332 vector by using T4 DNA ligase, transforming the connection product into Trans5 alpha competent cells, Amp resistance screening, and amplifying the 5S rRNA-KS-sgRNA fragment for verification, thereby obtaining the CRISPR/Cas9 vector of Phomopsis FS 508.
2. The construction method according to claim 1, wherein the 5S rRNA fragment has a nucleotide sequence shown in SEQ ID No.1, and the sgRNA fragment containing the target sequence has a nucleotide sequence shown in SEQ ID No. 2.
3. The CRISPR/Cas9 vector of the Phomopsis FS508, which is constructed according to the construction method of claim 1.
4. A fungus containing the CRISPR/Cas9 vector of Phomopsis FS508 of claim 3, which is Phomopsis FS 508.
5. Use of the CRISPR/Cas9 vector of Phomopsis FS508 of claim 3 for knock-out of Phomopsis FS508 gene.
6. Use according to claim 5, characterized in that it comprises the following steps: introducing the CRISPR/Cas9 vector of the phomopsis FS508 into a phomopsis FS508 protoplast by a protoplast-mediated method, screening by a hygromycin-resistant PDA plate, picking positive clones, extracting genome DNA to verify the introduction of the recombinant vector, and verifying the knockout of a target gene by sequencing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285033.7A CN112359043B (en) | 2020-11-17 | 2020-11-17 | CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011285033.7A CN112359043B (en) | 2020-11-17 | 2020-11-17 | CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112359043A CN112359043A (en) | 2021-02-12 |
CN112359043B true CN112359043B (en) | 2022-05-10 |
Family
ID=74515110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011285033.7A Active CN112359043B (en) | 2020-11-17 | 2020-11-17 | CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112359043B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112852647B (en) * | 2021-02-23 | 2022-06-07 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Overexpression vector suitable for phomopsis FS508 and construction method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3445844A4 (en) * | 2016-04-21 | 2019-11-13 | Naked Biome, Inc. | Synthetic bacteria and methods of use |
CN111902547A (en) * | 2018-03-23 | 2020-11-06 | 先锋国际良种公司 | Method for identifying, selecting and generating disease resistant crops |
CN109161480B (en) * | 2018-08-09 | 2022-01-11 | 南京师范大学 | Preparation method and gene knockout method of protoplast of phomopsis |
CN110283857A (en) * | 2019-06-18 | 2019-09-27 | 南京师范大学 | A method of naringenin is produced based on Phomopsis cell fermentation |
-
2020
- 2020-11-17 CN CN202011285033.7A patent/CN112359043B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN112359043A (en) | 2021-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105671070B (en) | A kind of CRISPRCas9 system and its construction method for Bacillus subtilis genes group editor | |
CN111057713A (en) | CRISPR/Cas9 vector applicable to erwinia bacterium FS110 and construction method and application thereof | |
CN109735537B (en) | Myrothecium roridum A553 trichothecene synthase gene Tri5 promoter and application thereof | |
CN111057654B (en) | Cas9 gene knockout vector applicable to morinda officinalis endophytic fungus A761 and construction method and application thereof | |
CN112553238B (en) | CRISPR/Cas9 vector applicable to coniothyrium minitans FS482 as well as construction method and application thereof | |
CN111073902A (en) | CRISPR/dCas9 vector for improving expression level of gliotoxin biosynthesis gene and construction method and application thereof | |
Chen et al. | Characterization of two polyketide synthases involved in sorbicillinoid biosynthesis by Acremonium chrysogenum using the CRISPR/Cas9 system | |
WO2019120132A1 (en) | Engineered strain for efficient heterologous expression of disorazole z, gene cluster for constructing the strain and applications thereof | |
CN112359043B (en) | CRISPR/Cas9 vector applicable to phomopsis FS508 and construction method and application thereof | |
CN113604472B (en) | CRISPR/Cas gene editing system applied to Trichoderma reesei | |
CN109666690B (en) | Method for over-expressing non-trace trichoderma fungus gene | |
CN112760338B (en) | CRISPR/Cpf1 vector suitable for deep-sea fungi FS140 and construction method and application thereof | |
Zhang et al. | Development of CRISPR-Cas9 genome editing system in Talaromyces marneffei | |
CN111073821B (en) | Construction method of monascus ruber strain capable of producing lovastatin with high yield and producing no citrinin | |
CN112538496A (en) | CRISPR/Cas9 vector applicable to Myrothecium roridum A553 as well as construction method and application thereof | |
CN115786385A (en) | CRISPR/Cas9 vector suitable for deep-sea fungus FS441 and construction method and application thereof | |
CN110564630A (en) | aspergillus ochraceus mutant strain with ochratoxin A gene knockout function and construction and application thereof | |
CN110628802A (en) | Sorangium cellulosum for high-yield epothilone D and construction method and application thereof | |
CN112852647B (en) | Overexpression vector suitable for phomopsis FS508 and construction method and application thereof | |
CN113980982B (en) | High-yield ansamitocin method for enhancing expression of ansamitocin in-vivo target protein gene | |
CN112899172B (en) | Homologous recombination efficient gene engineering bacterium of phoma sphingomyelina and construction method and application thereof | |
Su et al. | An efficient gene disruption method using a positive–negative split-selection marker and Agrobacterium tumefaciens-mediated transformation for Nomuraea rileyi | |
CN113913448B (en) | Method for improving yield of pyrroloquinoline quinone of methylotrophic bacteria and application | |
CN117264793B (en) | Method for improving beta-carotene production of yarrowia lipolytica through molecular docking, engineering bacteria obtained by method, construction method and application of engineering bacteria | |
CN114507684B (en) | Method for inhibiting target gene expression in Mediterranean salt-rich bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510070 No.56 courtyard, No.100 Xianlie Middle Road, Yuexiu District, Guangzhou City, Guangdong Province Patentee after: Institute of Microbiology, Guangdong Academy of Sciences Address before: 510070 No.56 courtyard, No.100 Xianlie Middle Road, Yuexiu District, Guangzhou City, Guangdong Province Patentee before: GUANGDONG INSTITUTE OF MICROBIOLOGY (GUANGDONG DETECTION CENTER OF MICROBIOLOGY) |
|
CP01 | Change in the name or title of a patent holder |